
    
      Inclusion Criteria:

        -  Male or female, 18 years of age or older.

        -  Ulcerative colitis described according to usual criteria, diagnosed for at least 1 year.

        -  Oral maintenance treatment with 5-aminosalicylic acid (5-ASA) only for at least 3 months
           with a dosage of 2 to 3 g/day.

        -  Clinical remission for at least 3 months (Mayo Clinic score) and endoscopic remission
           (endoscopic score of Mayo Clinic) at inclusion.

        -  Signed informed consent form.

      Exclusion Criteria:

        -  Patients allergic to aspirin or salicylates derivatives

        -  Patients taking the following treatments during the study will be excluded:
           corticosteroids (oral or rectal route), use of NSAID or Aspirin, any form of
           sulfasalazine, mesalazine or 4-ASA.

        -  Patients with known significant hepatic or known function abnormalities and/or creatine
           clearance â‰¤ 80 ml/min.

        -  Patients with history or physical examination findings indicative of active alcohol or
           drug abuse.

        -  Women who are pregnant or nursing.

        -  Patients with a history of disease, including mental/emotional disorder that would
           interfere with their participation in the study.

        -  Patients who participated in another clinical study in the last 3 months.

        -  Patients who are unable to comply with the requirements of the protocol

        -  Female of childbearing potential without efficacious contraception.
    
  